HEART TRANSPLANTATION

This study compares two solutions used to preserve donor hearts before transplant in children (birth to under 18). The new solution, Custodiol-N, is tested against the standard Custodiol to see if it is safe. Fifteen children awaiting their first heart transplant will take part. …

This study tests whether belatacept, an anti-rejection medication, is safe for adults who receive a heart transplant. About 12 participants will receive belatacept to prevent organ rejection. The goal is to see if it reduces serious complications like rejection, infection, or gra…

This study looks at fat cells around the heart arteries in 60 patients getting a heart transplant. Researchers want to see if the size of these fat cells is linked to artery disease. No new treatment is given—only measurements and analysis of tissue removed during the transplant.…

This study is testing whether a blood test that looks for donor DNA can help doctors spot heart transplant rejection earlier and more easily. Researchers will collect blood samples from 120 adult heart transplant recipients in Sweden and compare the results with standard heart bi…

This study looks at the long-term health of children (age 16 and older) whose mothers had a solid organ transplant before pregnancy. Researchers want to see if these children have higher risks for heart or kidney problems, possibly due to the mother's anti-rejection medicines. Ab…

This study looks at how small blood vessels in the skin react in people who have had a heart transplant. Researchers will use a non-invasive laser device to measure blood flow. The goal is to better understand heart and blood vessel health after transplant. About 31 participants …

This study follows 270 adults who have had or will have a heart transplant to see how their body's metabolism (how it uses energy) affects their heart and overall health. Researchers will track heart function, rejection signs, kidney health, infections, and other outcomes over ti…